James J. Harding, MD

88 posts

James J. Harding, MD banner
James J. Harding, MD

James J. Harding, MD

@HardingJJMD

Medical Oncologist | Clinical Investigator | Cancer Drug Developer | Associate Chair IRB | HPB Cancers | Phase 1 | MSKCC

New York Inscrit le Haziran 2023
329 Abonnements568 Abonnés
James J. Harding, MD retweeté
Ghassan Abou-Alfa
Ghassan Abou-Alfa@GABOUALFA·
It was a great honor and delight for @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA and @HardingJJMD to join this superb teaching effort. Thanks @oncodaily for the opportunity
OncoDaily@oncodaily

𝗛𝗼𝘄 𝗜 𝗧𝗿𝗲𝗮𝘁 𝗚𝗮𝗹𝗹𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗮𝗻𝗱 𝗕𝗶𝗹𝗲 𝗗𝘂𝗰𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗶𝗻 𝟮𝟬𝟮𝟲 | 𝗢𝗻𝗰𝗼𝗗𝗮𝗶𝗹𝘆 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗦𝘂𝗺𝗺𝗶𝘁 The Gallbladder and Bile Duct Cancer Summit 2026, organized by OncoDaily, brought together international experts to examine evolving clinical strategies and innovation shaping the management of gallbladder and biliary tract cancers. During this session, Ghassan Abou-Alfa (@GABOUALFA), James J Harding (@HardingJJMD), Vinay Kumar Kapoor (@vkkapoor_india) and Thatcher Heumann (@HeumannThatcher) shared expert perspectives on contemporary systemic therapy for biliary tract cancers, the fundamental “Ten Commandments” guiding gallbladder cancer management, practical approaches to treating gallbladder cancer in clinical practice, and emerging HER2- and RAS-targeted therapies shaping the future of hepatobiliary oncology.💡 Join the live conversation: x.com/i/broadcasts/1… #OncologySummit #GlobalOncology #CancerTreatment #OncoDaily #Oncology #Cancer #Health #Medicine #GallbladderCancer

English
1
2
15
1.2K
James J. Harding, MD retweeté
Arndt Vogel
Arndt Vogel@ArndtVogel·
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in #PDAC @JNCI_Now doi.org/10.1093/jnci/d… 🔎NRG1+ pts at Memorial Sloan Kettering 👉76,531 pts > 48 NRG1+ cases 👉Young pts, enriched in RAS WT PDAC 👉RNA testing is key @myESMO
Arndt Vogel tweet media
English
1
15
46
4.1K
James J. Harding, MD retweeté
Arndt Vogel
Arndt Vogel@ArndtVogel·
Final Results from a First-in-Human Phase I Study of the Dual IDH 1/2 Inhibitor, LY3410738, in Solid Tumors Harboring IDH1 or IDH2 Mutations @CCR_AACR doi.org/10.1158/1078-0… 🔎119 pts mono, 19 pts with CISGEM 👉ORR 5.2% & 11.1% 👉LY3410738 + CISGEM in BTC: ORR 42%, mPFS 8mo 🧐Could be interesting in BTC @myESMO @EASLedu
Arndt Vogel tweet media
English
1
20
48
3.6K
James J. Harding, MD retweeté
JAMA Oncology
JAMA Oncology@JAMAOnc·
For adults with metastatic HER2-positive #BiliaryTractCancer, zanidatamab led to longer overall survival and reduced pain, supporting its role as a precision therapy option. ja.ma/3LX1GuL
JAMA Oncology tweet media
English
2
11
32
4.2K
James J. Harding, MD retweeté
Midhun Malla
Midhun Malla@MallaMidhun·
GPC3 directed Radioligand Therapy in HCC: Honored to present Trials in Progress Poster @ESMO_Open @ONealCancerUAB. Great to run into good friend and collaborator, @HardingJJMD #esmo2025 Enrollment is ongoing!!
Midhun Malla tweet mediaMidhun Malla tweet mediaMidhun Malla tweet mediaMidhun Malla tweet media
English
1
6
29
2.7K
James J. Harding, MD retweeté
Dr Amol Akhade
Dr Amol Akhade@SuyogCancer·
🚨 New Molecules to Watch at #ESMO25 (GI Cancers) 🔹 KRAS G12D inhibitors (GFH375, HRS-4642, INCB161734) 🔹 Zanzalintinib + Atezolizumab (STELLAR-303, mCRC) 🔹 Sirexatamab (DKN-01, MSS mCRC) 🔹 RC118 (CLDN18.2 ADC, Gastric/GEJ) 🔹 Telisotuzumab Adizutecan (c-MET ADC) 🔹 Nofazinlimab + Lenvatinib (HCC) 🔹 Tiragolumab + Atezo+Bev (HCC) 🔹 Bemarituzumab + Chemo (FGFR2b+, Gastric/GEJ) Precision oncology pipeline heating up 🔥 @myESMO
Dr Amol Akhade tweet media
English
0
40
136
12.1K
James J. Harding, MD
James J. Harding, MD@HardingJJMD·
Looking forward to #HBP oral #ESMO25 @myESMO @MSK_DeptOfMed, honor to present re: #MET as a target.
Erman Akkus@Erman_Akkus

📢Biliary tract, HCC and pancreatic cancers oral abstracts in #ESMO25 @myESMO 👇 😍There are a lot of oral upper GI abstracts in #ESMO25. I am sure that some are practice-changing but all will give very important insights for practice! #cancer #oncology #GI #biliary #cholangiocarcinoma #hcc #liver #pancreatic @OncoAlert @realbowtiedoc

English
0
1
11
402

Découvrir

@GABOUALFA @MSK_DeptOfMed @theNCI @EileenMOReilly @YJanjigianMD @DSolit @OlcaBasturk @MskccCMO